Bayer Reports Positive Phase III Results for I-124...
Category : Clinical Trial Update 2 September 2026REVEAL Study Meets Primary Diagnostic Endpoints Bayer has announced the first detailed results fr...
Clinical Trial Update
Novartis Reports Positive Phase III Results for Re...
Category : Clinical Trial Update 2 September 2026REMODEL-1 and REMODEL-2 Trials Show Lower Relapse Rates Novartis has announced positive topline r...
Zydus Reports Positive Phase II(b) Results for Sar...
Category : Clinical Trial Update 1 September 2026EVIDENCES-X Study Meets Its Primary Endpoint Zydus Lifesciences Limited has reported positive top...
Veloxis Doses First Participant in Phase 2 Trial o...
Category : Clinical Trial Update 1 September 2026New Study Looks at an Alternative to Tacrolimus for Long-Term Immunosuppression Veloxis Pharmaceu...
Roche Reports Two-Year Vabysmo Data Showing Sustai...
Category : Clinical Trial Update 31 August 2026SALWEEN Study Shows Continued Improvements in Vision and Retinal Health Roche has announced new t...
Latest Newsletter Post
-
Novartis Reports Positive Phase III..
2 September 2026
-
Bayer Reports Positive Phase III Re..
2 September 2026
-
Veloxis Doses First Participant in..
1 September 2026
-
Zydus Reports Positive Phase II(b)..
1 September 2026
-
Ascletis Starts Phase III Trials of..
31 August 2026
